Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre- and postconditioning against myocardial infarction in mice in vivo

Experimental Biology and Medicine

Volumn 234, Issue 10, 2009, Pages 1186-1191

  Redel, Andreas ^a   Stumpner, Jan ^a   Tischer Zeitz, Tobias ^a   Lange, Markus ^a   Smul, Thorsten M ^a   Lotz, Christopher ^a   Roewer, Norbert ^a   Kehl, Franz ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Klinikum Karlsruhe   (Germany)

Author keywords

Anesthetic postconditioning; Anesthetic preconditioning; Ischemic postconditioning; Ischemic preconditioning; Mouse; Myocardial infraction

Indexed keywords

DESFLURANE; EVANS BLUE; ISOFLURANE; SEVOFLURANE; TRIPHENYLTETRAZOLIUM;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HEART INFARCTION; HEART INFARCTION SIZE; IN VIVO STUDY; INSTRUMENTAL CONDITIONING; ISCHEMIA; MALE; MOUSE; NONHUMAN; REPERFUSION;

MURINAE; MUS;

EID: 70349694536     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0902-RM-58     Document Type: Article

References (33)

1. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Is isoflurane-induced preconditioning dose related? Anesthesiology 96(3):675-680, 2002.
2. Smul T, Redel A, Stumpner J, Lange M, Lotz C, Roewer N, et al. The time course of desflurane-induced preconditioning in rabbits. J Cardiothorac Vasc Anesth, submitted 2009.
3. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102(1):102-109, 2005.
4. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 103(5):987-995, 2005. (Pubitemid 41552054)
5. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 97(2):127-136, 2006.
6. Jakobsen CJ, Berg H, Hindsholm KB, Faddy N, Sloth E. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 21(5):664-671, 2007. (Pubitemid 47464955)
7. Ljubkovic M, Mio Y, Marinovic J, Stadnicka A, Warltier DC, Bosnjak ZJ, et al. Isoflurane preconditioning uncouples mitochondria and protects from hypoxia/reoxygenation. Am J Physiol Cell Physiol 292(5):1583-1590, 2007. (Pubitemid 47082397)
8. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 91(4):551-565, 2003. (Pubitemid 37264906)
9. Tsutsumi YM, Patel HH, Huang D, Roth DM. Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice. Am J Physiol Heart Circ Physiol 291(2):H979-H983, 2006. (Pubitemid 44175109)
10. Tsutsumi YM, Patel HH, Lai NC, Takahashi T, Head BP, Roth DM. Isoflurane produces sustained cardiac protection after ischemia-reperfusion injury in mice. Anesthesiology 104(3):495-502, 2006.
11. Redel A, Lange M, Jazbutyte V, Lotz C, Smul TM, Roewer N, et al. Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning. Anesth Analg 106(2):384-391, 2008. (Pubitemid 351156658)
12. Bayne K. Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 39(4):199, 208-211, 1996.
13. Redel A, Jazbutyte V, Smul TM, Lange M, Eckle T, Eltzschig H, et al. Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) 233(1):84-93, 2008.
14. Eckle T, Grenz A, Kohler D, Redel A, Falk M, Rolauffs B, et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 291(5):H2533-H2540, 2006. (Pubitemid 44776685)
15. Sonner JM, Gong D, Eger EI 2nd. Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg 91(3):720-726, 2000.
16. Liao M, Laster MJ, Eger EI, Tang M, Sonner JM. Naloxone does not increase the minimum alveolar anesthetic concentration of sevoflurane in mice. Anesth Analg 102(5):1452-1455, 2006.
17. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, et al. Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269(6 Pt 2):H2147-H2154, 1995. (Pubitemid 26023233)
18. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 275(4 Pt 2):H1375-H1387, 1998. (Pubitemid 28491900)
19. Miller DL, Van Winkle DM. Ischemic preconditioning limits infarct size following regional ischemia-reperfusion in in situ mouse hearts. Cardiovasc Res 42(3):680-684, 1999.
20. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 283(4):H1740-H1742, 2002.
21. Hampton CR, Shimamoto A, Rothnie CL, Griscavage-Ennis J, Chong A, Dix DJ, et al. HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts. Am J Physiol Heart Circ Physiol 285(2):H866-H874, 2003. (Pubitemid 36885921)
22. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 75(3):530-535, 2007. (Pubitemid 47080966)
23. Piriou V, Chiari P, Lhuillier F, Bastien O, Loufoua J, Raisky O, et al. Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium. Br J Anaesth 89(3):486-491, 2002. (Pubitemid 34993981)
24. Frantz S, Brandes RP, Hu K, Rammelt K, Wolf J, Scheuermann H, et al. Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX. Basic Res Cardiol 101(2):127-132, 2006. (Pubitemid 43250804)
25. Frantz S, Calvillo L, Tillmanns J, Elbing I, Dienesch C, Bischoff H, et al. Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the alpha-glucosidase inhibitor acarbose. FASEB J 19(6):591-593, 2005. (Pubitemid 40471254)
26. Frantz S, Ducharme A, Sawyer D, Rohde LE, Kobzik L, Fukazawa R, et al. Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol 35(6):685-694, 2003. (Pubitemid 36677452)
27. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104(3):271-280, 1999.
28. Illert B, Otto C, Thiede A, Timmermann W. Detection of disseminated tumor cells in nude mice with human gastric cancer. Clin Exp Metastasis 20(6):549-554, 2003. (Pubitemid 37297183)
29. Sitaru AG, Timmermann W, Ulrichs K, Otto C. Hierarchical immunogenicity of donor MHC class I peptides in allotransplantation. Hum Immunol 63(10):871-879, 2002. (Pubitemid 35246767)
30. Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 115(4):870-878, 2005. (Pubitemid 40489391)
31. Timm S, Otto C, Begrich D, Moskalenko V, Hamelmann W, Ulrichs K, et al. Immunogenicity of parathyroid allografts in the rat: immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants are not effective in parathyroid gland transplants with few passenger leukocytes. Langenbecks Arch Surg 389(1):46-52, 2004. (Pubitemid 38200271)
32. Lange M, Redel A, Smul T, Lotz C, Nefzger T, Stumpner J, et al. Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta2-adrenergic receptors. J Cardiothorac Vasc Anesth, in press, 2009.
33. Ito WD, Schaarschmidt S, Klask R, Hansen S, Schafer HJ, Mathey D, et al. Infarct size measurement by triphenyltetrazolium chloride staining versus in vivo injection of propidium iodide. J Mol Cell Cardiol 29(8):2169-2175.